You are using an outdated browser. Please upgrade your browser to improve your experience.

Tbio
MAGEA12
Melanoma-associated antigen 12

Protein Summary
Description
Not known, though may play a role tumor transformation or progression. In vitro promotes cell viability in melanoma cell lines. This gene is closely related to several other genes clustered on chromosome X. These genes may be overexpressed in tumors. Multiple alternatively spliced variants encoding the same protein have been identified. [provided by RefSeq, Jun 2014]
Uniprot Accession IDs
Gene Name
Ensembl ID
  • ENST00000357916
  • ENSP00000350592
  • ENSG00000213401
  • ENST00000393869
  • ENSP00000377447
  • ENST00000393900
  • ENSP00000377478

Symbol
  • MAGE12
  • CT1.12
  • MAGE12
Illumination Graph
Knowledge Table
Most Knowledge About
Knowledge Value (0 to 1 scale)
cell type or tissue
0.69
tissue sample
0.69
PubMedID
0.45
chemical
0.43
protein domain
0.41


Related Tools
GENEVA
GENEVA (GENe Expression Variance Analysis) allows you to identify RNA-sequencing datasets from the Gene Expression Omnibus (GEO) that contain conditions modulating a gene or a gene signature.
GlyGen
GlyGen is a data integration and dissemination project for carbohydrate and glycoconjugate related data.
ARCHS4
ARCHS4 provides access to gene-function predictions based on RNA-seq co-expression, and gene expression levels across cell and tissues.
IDG Development Level Summary
Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 15.07   (req: < 5)
Gene RIFs: 5   (req: <= 3)
Antibodies: 125   (req: <= 50)
Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 15.07   (req: >= 5)
Gene RIFs: 5   (req: > 3)
Antibodies: 125   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Term: 0
Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0
Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0
Protein Structure (0 Structures, 1 AlphaFold Model)
RepresentationColor Scheme
AF-P43365-F1-model_v1

AlphaFold Structures Developed by DeepMind and EMBL-EBI

Protein-Protein Interactions (36)
1 – 10 of 36
CSAG1
Tbio
Novelty: 0.16422262
Score: 0.919
Data Source: STRINGDB
MAGEA3
Tbio
Novelty: 0.00285779
Score: 0.774
Data Source: STRINGDB
MAGEA6
Tbio
Novelty: 0.06942953
Score: 0.773
Data Source: STRINGDB
GAGE2A
Tdark
Novelty: 0.17251368
Score: 0.745
Data Source: STRINGDB
GAGE12F
Tdark
Novelty: 0.01850125
Score: 0.701
Data Source: STRINGDB
GAGE12I
Tbio
Novelty: 0.01850125
Score: 0.701
Data Source: STRINGDB
GAGE2E
Tdark
Novelty: 7.83744279
Score: 0.685
Data Source: STRINGDB
CTAG1A
Tbio
Novelty: 0.00345306
Score: 0.683
Data Source: STRINGDB
MAGEA2
Tbio
Novelty: 0.03638671
Score: 0.678
Data Source: STRINGDB
GAGE7
Tbio
Novelty: 0.0195995
Score: 0.648
Data Source: STRINGDB
Publication Statistics
PubMed Score  15.07

PubMed score by year
PubTator Score  12.71

PubTator score by year
Amino Acid Sequence
Residue Counts
Protein Sequence
ProtVista Viewer